Comparing two pain management techniques for breast surgery
The Effect of Adding Pectointercostal Plane Block to Serratus Anterior Plane Block on Postoparative Pain Management in Patient Planned for Breast Surgery
This study is testing if adding a new pain relief technique to standard care can help women feel less pain after breast surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | Female |
| Sponsor | Uludag University Academic / other |
| Locations | 1 site (Bursa) |
| Trial ID | NCT06129383 on ClinicalTrials.gov |
What this trial studies
This clinical study aims to evaluate the effectiveness of adding a pecto-intercostal fascial plane block to the serratus anterior plane block for postoperative pain management in women scheduled for breast surgery. The study will include women aged 18 to 75 who meet specific health criteria and will be divided into two groups: one receiving only the serratus anterior plane block and the other receiving both blocks. The researchers will analyze pain levels and recovery outcomes to determine the benefits of the additional block. A total of 60 participants will be enrolled, with careful monitoring of their health status throughout the study.
Who should consider this trial
Good fit: Ideal candidates are women aged 18 to 75 scheduled for breast surgery who are in ASA class I-III and can provide informed consent.
Not a fit: Patients with known allergies to local anesthetics, severe comorbidities, or those on chronic opioid therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve postoperative pain management for breast surgery patients.
How similar studies have performed: Previous studies have shown promising results with similar pain management techniques, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * American Society of Anesthesiologists (ASA) class I-III groups, * not pregnant or suspected of being pregnant * approve the informed consent form will be included in the study. Exclusion Criteria: * Patients with known local anesthetic allergy or suspected coagulopathy, * Infection on injection area * Serious neurological disorder * Psychiatric disorder * Severe cardiovascular disease * Liver failure * Renal failure * Using chronic opioid
Where this trial is running
Bursa
- Uludagu — Bursa, Turkey (Recruiting)
Study contacts
- Study coordinator: Özlem Gök
- Email: ozlmgktp@gmail.com
- Phone: +905469379652
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.